AYOLLAR BACHADON MIOMASINING YOSHGA XOS MORFOLOGIK XUSUSIYATLARI
Keywords:
Bachadon miomasi, leiomioma, yosh omili, morfologik xususiyatlar, proliferatsiya, degeneratsiya, gialinoz, kalsifikatsiya, reproduktiv yosh, perimenopauza, postmenopauza, gormonal ta’sirAbstract
Bachadon miomasi — ayollar reproduktiv tizimining eng keng tarqalgan benign o‘smalaridan biri bo‘lib, uning rivojlanishi yoshga bog‘liq holda klinik va morfologik jihatdan turlicha namoyon bo‘ladi. Ushbu maqolada bachadon miomasining turli yosh guruhlarida uchrash xususiyatlari, o‘sma tugunlarining morfologik tuzilishi, degenerativ o‘zgarishlari hamda gormonal fon bilan bog‘liqligi tahlil qilinadi. Yosh reproduktiv davrda mioma hujayralarining proliferativ faolligi yuqori bo‘lib, tugunlar tez o‘sish tendensiyasiga ega. Perimenopauza va postmenopauza davrida esa o‘sma involyutsiyasi, fibrozlashuv va degenerativ jarayonlar ustunlik qiladi. Morfologik jihatdan mioma tugunlarida gialin degeneratsiya, kalsifikatsiya, kistoz o‘zgarishlar va kam hollarda nekroz kuzatiladi. Tadqiqot natijalari yoshga xos morfologik o‘zgarishlarni aniqlash orqali diagnostika va davolash strategiyalarini individuallashtirishda muhim ahamiyatga ega ekanligini ko‘rsatadi.
References
1. Stewart E. A.. Uterine fibroids. The Lancet. 2015; 357(9252): 293–298.
2. Baird D. D., Dunson D. B., Hill M. C., Cousins D., Schectman J. M. High cumulative incidence of uterine leiomyoma. American Journal of Obstetrics and Gynecology. 2003; 188(1): 100–107.
3. Bulun S. E.. Uterine fibroids. New England Journal of Medicine. 2013; 369: 1344–1355.
4. Cramer S. F., Patel A. The frequency of uterine leiomyomas. American Journal of Clinical Pathology. 1990; 94(4): 435–438.
5. Flake G. P., Andersen J., Dixon D. Etiology and pathogenesis of uterine leiomyomas. Environmental Health Perspectives. 2003; 111(8): 1037–1054.
6. Laughlin-Tommaso S. K.. Epidemiology and management of uterine fibroids. Clinical Obstetrics and Gynecology. 2016; 59(1): 2–24.
7. Okolo S.. Incidence, etiology and epidemiology of uterine fibroids. Best Practice & Research Clinical Obstetrics & Gynaecology. 2008; 22(4): 571–588.
8. Parker W. H.. Etiology, symptomatology, and diagnosis of uterine myomas. Fertility and Sterility. 2007; 87(4): 725–736.
9. Robboy S. J., Mutter G. L., Prat J. Robboy's Pathology of the Female Reproductive Tract. 2nd ed. Elsevier; 2009.
10. Kumar V., Abbas A. K., Aster J. C. Robbins and Cotran Pathologic Basis of Disease. 10th ed. Elsevier; 2020.
11. Hoffman B. L. et al. Williams Gynecology. 4th ed. McGraw-Hill; 2020.
12. World Health Organization. WHO guidelines on reproductive health and uterine fibroids. Geneva; 2021.
13. American College of Obstetricians and Gynecologists. Management of symptomatic uterine leiomyomas. Practice Bulletin No. 228; 2021.
14. Ministry of Health of the Republic of Uzbekistan. Ayollar reproduktiv salomatligi bo‘yicha milliy qo‘llanma. Toshkent; 2022.
